New Concepts and Recent Advances in the Management of Skin Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Cancer Epidemiology and Prevention".
Deadline for manuscript submissions: 31 August 2025 | Viewed by 20127
Special Issue Editors
Interests: dermatology; skin cancer; dermatological surgery; Mohs surgery; pigmented lesions; dermoscopy; photodynamic therapy
Special Issues, Collections and Topics in MDPI journals
Interests: dermatologic surgery; Mohs surgery; forehead flaps; skin cancer; vascular malformations; congenital melanocytic nevi; cutaneous reconstructive surgery
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Skin cancer is the most common human cancer and its incidence is continuosly increasing. The recent discovery of new signaling pathways related with melanoma and keratynocitic carcinomas has transformed the therapeutic landscape of this cutaneous tumors. New diagnostic tools have also been developed, leading to an earlier diagnosis and optimizing the clinical management of these tumours. However, there are still many uncertainties in the field of cutaneous oncology in need of covering for a better understanting and handling of the disease.
In this Special Issue, papers on epidemiology, etiopathogenic mechanisms, clinical management and surgical/medical therapy in skin cancer are highly welcome.
Researchers are encouraged to submit their findings as either original articles, reviews, or brief communications.
Dr. Rafael Salido-Vallejo
Dr. Pedro Redondo
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- skin cancer
- basal cell carcinoma
- cutaneous squamous cell carcinoma
- melanoma
- Merkel cell carcinoma
- cutaneous sarcomas
- treatment
- checkpoint inhibitors
- epidemiology
- dermatologic surgery
- extramammary paget's disease
- cutaneous lymphoma
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue polices can be found here.